Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Publication Rates of Oculoplastic Surgery and Orbit Abstracts Presented at Turkish Ophthalmological Association National Congresses: 10-Year Analysis.
Turk J Ophthalmol
December 2024
Ankara Bilkent City Hospital, Clinic of Ophthalmology, Ankara, Türkiye.
Objectives: This study aimed to examine the publication rates of abstracts related to oculoplastic surgery and orbital diseases presented at the Turkish Ophthalmological Association National Congresses (TOA-NCs) in 2013-2022.
Materials And Methods: The study included abstracts in the field of oculoplastic surgery and orbital diseases accepted for presentation at TOA-NCs between 2013 and 2022. These abstracts were reviewed in terms of presentation type (oral, poster), number of authors, study setting (university, training and research, private, public, or abroad hospital), study type (case, clinical, or basic science), study topic (eyelid, lacrimal system, orbit, or thyroid eye disease), journal publication status, time to publication (months), publishing journal (national, international), and journal impact factor.
Clinical predictors of 3-month isoniazid rifapentine (3HP)-related adverse drug reactions (ADR) during tuberculosis preventive therapy (PAnDoRA-3HP study): an observational study protocol.
BMJ Open
December 2024
Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Central, Uganda.
Introduction: Tuberculosis (TB) is the leading infectious cause of death globally. Despite WHO recommendations for TB preventive therapy (TPT), challenges persist, including incompletion of treatment and adverse drug reactions (ADRs). There is limited data on the 3-month isoniazid and rifapentine (3HP) pharmacokinetics, pharmacogenomics and their relation with ADRs.
View Article and Find Full Text PDFNo abstract available.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!